Search
Close this search box.

A scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on June 27, 2024, in Tehran’s Emam khomeini Hospital by Kimiaara Company

مورنینگ علمی فبیکس بیمارستان امام

A scientific morning related to symptomatic and asymptomatic hyperuricemia and its prevalence in Iran and the world was held on June 27, 2024, in Tehran’s Emam khomeini Hospital by Kimiaara Company.

In this meeting, Dr. Rahimi, medical advisor of company, discussed about the treatment protocol for symptomatic hyperuricemia according to the latest ACR guidelines, as well as the prescription of blood uric acid-lowering drugs in hyperuricemic patients without clinical symptoms in high-risk patients, including patients with moderate to severe renal failure , peri dialysis and dialysis, kidney stone and kidney transplant.

This scientific morning was held on Thursday, June 27, 2024. with the presence of respected professors of nephrology and kidney transplantation:

Dr. Mohamadreza Khatami

Dr. Mohamadreza Abbasi

Dr. Azam Alamdari

Dr. Farzaneh Sadat Minoo

Dr. Ali Ghafari Moghadam

Dr. Mohamadtaghi Najafi

Dr. Nasrin Rezvandust

Dr. Simin Dashti as Clinical pharmacist

And also, Nephrology fellowships.

مورنینگ علمی فبیکس بیمارستان امام مورنینگ علمی فبیکس بیمارستان امام

At the end of this session, precious professors commented on the comparison of the efficacy and safety of febuxostat molecule and its superiority over allopurinol in various hyperuricemic and kidney failure patients.

The febuxostat molecule bioequivalence studies about Febix with Adenoric brand of Menarini company were investigated, and the results show that Febix is therapeutically equivalent to the originator of Menarini company according to the bioequivalence criteria approved by FDA.

Similar news ...

Shahid Madani Tabriz Heart Center morning meeting

Shahid Madani Tabriz Heart Center morning meeting was held on july 23, 1400 on the role of Ticagrelor. in the treatment of Acute Coronary Syndrome and presentation of clinical studies. This meeting was held in the presence of respected professors, including: Interventionist: Dr.Separham, Dr.Ghaffari Dr.Aslan Abadi Dr.Sohrabi Electrophysiologist: Dr.Abbas Nezhad

Read more...

Scientific program of Tehran Heart Center Cath Conference

Holding the scientific program of Tehran Heart Center Cath Conference with lecture of Dr. Rahimi, (Kimiara Company’ Medical Science Liaison), on the role of Ticagloror molecule in the treatment of Acute Coronary Syndrome and review of clinical studies on Thursday, July 24, 1400. In this scientific meeting: The superior properties

Read more...
مورنینگ علمی فوریمو بیمارستان شهدای تجریش

Scientific morning of shohadaye tajrish Hospital

A scientific morning session on the new strategy in pain management with high-dose ibuprofen and also addressing osteoporosis with a new form of calcium supplement was held on Saturday, May 18, 2024, in Tajrish Hospital. In this session, Dr. Rahimi, the medical advisor of the company, presented the prevalence of

Read more...